ASX:QBE
ASX:QBEInsurance

3 ASX Dividend Stocks Yielding Up To 4.1%

The Australian market has faced a challenging week, with the ASX200 slipping into negative territory amid a cautious mood influenced by economic concerns both locally and from the US. As investors navigate these turbulent times, dividend stocks can offer some stability and income potential, making them an attractive option for those seeking to balance risk in their portfolios.
ASX:JMS
ASX:JMSMetals and Mining

Aims Property Securities Fund And 2 Other ASX Penny Stocks To Watch

The Australian market has recently faced a challenging period, with the ASX200 experiencing declines amid negative sentiment from the US and domestic economic concerns. Despite these broader market conditions, there are still opportunities for investors willing to explore beyond well-known stocks. Penny stocks, often associated with smaller or newer companies, continue to offer intriguing prospects for growth at lower price points. In this article, we examine three penny stocks that stand out...
ASX:CUV
ASX:CUVBiotechs

How Investors Are Reacting To Clinuvel Pharmaceuticals (ASX:CUV) SEC Filing Delays Amid US Government Disruptions

Clinuvel Pharmaceuticals announced that delays in the U.S. Federal government's operations have affected the review and approval timelines for its registration statements submitted to the SEC. This development highlights how external regulatory factors, such as government shutdowns, can meaningfully influence timelines and operational certainty for international biopharmaceutical companies. We’ll explore how these government-related approval delays could impact Clinuvel’s growth outlook and...
ASX:CSL
ASX:CSLBiotechs

A Closer Look at CSL (ASX:CSL) Valuation Following Capital Markets Day and Guidance Downgrade

CSL (ASX:CSL) is in the spotlight as it hosts its Capital Markets Day event, presenting strategic priorities and growth initiatives for investors. The timing comes after a recent guidance downgrade and market volatility. See our latest analysis for CSL. Despite promising long-term trends in core plasma and vaccine markets, CSL’s share price return has slid sharply this year, with a 30-day drop of 14.3% and a year-to-date fall of 37.3%. After briefly rallying on hopes for operational...
ASX:WBC
ASX:WBCBanks

Westpac (ASX:WBC) Dividend Announcement Prompts Fresh Look at Valuation and Shareholder Returns

Westpac Banking (ASX:WBC) just declared an ordinary dividend of A$0.77 per share for the six months to September 2025. This offers investors a fresh look at shareholder returns and reflects the bank’s confidence in its outlook. See our latest analysis for Westpac Banking. Westpac’s recent dividend news landed just as the bank’s shares have been showing renewed momentum, with a 24.07% year-to-date share price return and an impressive 30.78% total shareholder return over the past year. Compared...
ASX:AX1
ASX:AX1Specialty Retail

Will Accent Group's (ASX:AX1) New People Leaders Transform Its Competitive Edge in Retail?

Accent Group recently appointed Debbie Hinbest as Executive Director of People, Culture and Transformation, and Steve Morris as Executive Director of Development and Sales, following a comprehensive recruitment process. The addition of leaders with deep experience in organisational culture and development signals a renewed focus on people strategy and growth initiatives. We'll explore how these executive appointments could shape Accent Group's ongoing transformation, particularly regarding...
ASX:WDS
ASX:WDSOil and Gas

Does Woodside Offer Value After LNG Investment Announcement and a 14.5% Rise in 2025?

Curious if Woodside Energy Group stock is a genuine bargain or just riding the waves? Let’s dig into what’s really behind its current price tag. Shares have moved up 4.1% over the past week and are now up 14.5% for the year, pointing to renewed optimism and perhaps changing views on future prospects. The stock has drawn attention lately after the company announced additional investment in its LNG projects, which industry watchers believe could drive long-term growth. Broader energy market...
ASX:PME
ASX:PMEHealthcare Services

Is Pro Medicus (ASX:PME) Facing a Realignment of Market Momentum or Just Technical Noise?

Pro Medicus recently appeared on the ASX Downtrends Scan List, reflecting a technical downtrend and increased selling pressure in its shares. This development highlights a shift in sentiment among short-term traders, who appear to be reacting to indicators of excess supply and momentum. We'll examine how heightened selling pressure and technical signals are shaping Pro Medicus's current investment narrative. AI is about to change healthcare. These 33 stocks are working on everything from...
ASX:SHL
ASX:SHLHealthcare

Sonic Healthcare (ASX:SHL): Evaluating Value After This Year’s Share Price Drop and Steady Revenue Growth

Sonic Healthcare (ASX:SHL) has caught attention lately, as its stock price dropped 24% since January. While the market has sold off, the company’s revenue continues to edge higher. Its shares now trade below their five-year average price-to-sales ratio. See our latest analysis for Sonic Healthcare. After a tough year, Sonic Healthcare’s share price has fallen 24.4% year-to-date. This reflects a shift in sentiment as investors weigh its steady revenue growth against changing market risks...
ASX:NSR
ASX:NSRSpecialized REITs

Does National Storage REIT’s Expansion Signal Real Value After a 6% Share Price Dip?

Curious whether National Storage REIT might be a hidden gem or an overhyped pick? Let's take a closer look at what could be shaping its true value. The stock has seen a dip of 6.2% over the last week and is down 4.8% over the past year, although its five-year return still stands strong at 56.3%. Recent news highlights the company's ongoing expansion efforts with strategic property acquisitions and enhanced sustainability initiatives. Both of these have stirred fresh interest from investors...
ASX:XRO
ASX:XROSoftware

Xero (ASX:XRO): Assessing Valuation After Strong ASX 200 Performance and Digital Transformation Gains

Recent coverage has drawn attention to Xero (ASX:XRO) and its sustained performance within the ASX 200. It highlights both its consistent market fundamentals and its impact on digital transformation for Australian small and medium businesses. See our latest analysis for Xero. After a strong year of innovation and sustained relevance within the ASX 200, Xero’s share price has eased to A$145.98, with recent volatility, such as a -5.07% slide over the last week and a -9.3% dip for the month,...
ASX:CLV
ASX:CLVChemicals

Clover And 2 Other ASX Penny Stocks To Watch

With the Reserve Bank's recent decision to hold interest rates steady and earnings season concluded, Australian shares are experiencing a period of uncertainty, with the ASX 200 attempting to rebound from a six-week low. In this context, penny stocks—though an older term—remain relevant for investors seeking opportunities in smaller or emerging companies that may offer growth potential. By focusing on those with solid financial health and clear growth prospects, investors can uncover...
ASX:SUL
ASX:SULSpecialty Retail

Super Retail Group (ASX:SUL): Valuation Insights Following New CEO Appointment and Leadership Transition

Super Retail Group (ASX:SUL) has named Paul Bradshaw as its next CEO, effective November 1, 2025, following the recent departure of its previous chief executive due to governance issues. Bradshaw’s three decades of retail leadership could signal a stable transition for investors. See our latest analysis for Super Retail Group. Super Retail Group’s leadership updates come on the heels of a solid long-term run for investors. The total shareholder return over the past year stands at 17%, and an...